about
CD72 negatively regulates KIT-mediated responses in human mast cellsExpression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretionMast cell homeostasis and the JAK-STAT pathwayCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsKIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisFunctional deregulation of KIT: link to mast cell proliferative diseases and other neoplasmsThe production of alpha/beta and gamma/delta double negative (DN) T-cells and their role in the maintenance of pregnancyThe PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophilsThe adaptor 3BP2 is required for KIT receptor expression and human mast cell survivalRIN3 is a negative regulator of mast cell responses to SCF.Brain mast cells link the immune system to anxiety-like behavior.UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulationCirculating tryptase as a marker for subclinical atherosclerosis in obese subjects.Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?IgE, mast cells, basophils, and eosinophils.Disturbed spermatogenesis associated with thickened lamina propria of seminiferous tubules is not caused by dedifferentiation of myofibroblasts.Lysosomal membrane permeabilization induces cell death in human mast cells.IL-33/ST2 axis promotes mast cell survival via BCLXL.Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.Mast cell activation syndrome: Proposed diagnostic criteria.ADAM10 is required for SCF-induced mast cell migrationMast cell activation syndromes: definition and classification.Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.BCR-ABL but not JAK2 V617F inhibits erythropoiesis through the Ras signal by inducing p21CIP1/WAF1.Glycogen synthase kinase 3beta activation is a prerequisite signal for cytokine production and chemotaxis in human mast cellsP2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells.A novel FcεRIβ-chain truncation regulates human mast cell proliferation and survivalMast cell function: a new vision of an old cell.Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosisAdvances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.Mast cells and neuroinflammation.Diagnosis and treatment of mast cell disorders: practical recommendations.Increased differentiation of dermal mast cells in mice lacking the Mpl gene.Gabapentin, a synthetic analogue of gamma aminobutyric acid, reverses systemic acute inflammation and oxidative stress in mice.Systemic mastocytosis: a rare cause of single vertebral body uptake on bone scan.Bullous mastocytosis in a 3-month-old infantLong-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemiaGlycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasisDefinitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalmTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.
P2860
Q24297400-E41AFA72-3900-47E9-BAA2-6175881F19DAQ24311326-4DD48FF7-EC3D-47E3-9CA2-1E9756A34D39Q24632515-B02A1E8B-C0C3-49C0-85F5-F09C07D505F1Q26778929-0CD6D0BC-8355-4D51-BB43-F56ECE9EBE06Q26830207-BC775EAD-EFB2-4220-90D5-B822B2EE801CQ26995624-CAF2B8E1-B152-456F-B65F-6A2259D10F42Q28087072-549CBDA6-25AB-484C-97AB-16187B2FCB57Q28480417-DBD1EF14-8524-4A9F-A274-831BBE0574F7Q30009200-B208B60C-714E-49AC-B34D-A3BB8BC60CF4Q30423833-CAFCCAD3-4596-486A-A374-37B6FB637F84Q30484650-D1840E3F-4F7E-4B3A-ABBB-E38AFE12B58EQ33615486-3E0D91CD-122B-4CEF-BFAE-6749C3956BE0Q33618430-7B90035E-187F-48AA-BB74-1CF8ABC1EC98Q33658543-900E2862-0844-480C-B1AD-194D11A8D79BQ33760398-74CA278E-3CA4-45F0-ACCF-167DF0567A0CQ33863416-3F8A3BA5-CBDB-40B0-A929-1733DAE9EE2AQ33924209-0E802D1D-41B8-4D7C-B79E-B085368B76DFQ33925929-31BCC33E-8B4D-419B-B6B7-36FCACE78203Q34017091-D94A6FF5-D5E8-4AC7-A8A7-D5047ACAE234Q34024510-FAD9A54F-8A25-4715-9B2C-7AF10A00EEADQ34026123-6746C036-0E0D-48F5-B314-9E6BC8F05B66Q34035582-C2C4B103-0934-4FB9-89F8-4B79A06AE6E7Q34073540-78CB3C16-6BE1-45D3-BD7D-75F741FD2F4DQ34181572-23C2CA7F-BA05-465D-94EC-2C3676C97461Q34214029-E84349B1-DF70-4004-B0F1-203B29F2F327Q34283297-5DFCA232-37E5-43FE-9586-08C2816A4657Q34378845-2D6EB36D-D847-47C4-8022-EBD2AB6194DFQ34430917-52E25196-A531-4247-A8B2-87D277D71088Q34545350-B9252E1F-3312-47F7-88A9-4CE4A90CDDF1Q34552564-F29B67DA-6715-4740-9034-9CC27C44EA08Q34810678-D667172D-B535-4612-ACF4-DF35FF225CA0Q35021196-B5F7A2C1-195E-4504-9F0B-BDA92F3D6BECQ35101887-5A2B3843-B684-4EB7-9CBF-95B8C1589E1AQ35164203-4C639735-5C8C-4707-A6FC-C7399D0079A4Q35346111-4C56E5F7-ED3E-42DA-BF0C-28ACB364CBD8Q35420169-8C5B82C2-A82E-4BE4-ACEC-5CE271FF382BQ35550174-45F2B71F-7E75-491D-AD10-F855265B1624Q35566591-11E9E4F0-C8B6-4A03-9B63-4CB87CA619FBQ35574171-F5442881-A7BD-4AD6-9677-A314982B8903Q35631301-D8511214-7008-472B-A2D6-1D0C69519A1B
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mast cells and mastocytosis.
@en
type
label
Mast cells and mastocytosis.
@en
prefLabel
Mast cells and mastocytosis.
@en
P2860
P1433
P1476
Mast cells and mastocytosis.
@en
P2093
Dean D Metcalfe
P2860
P304
P356
10.1182/BLOOD-2007-11-078097
P407
P577
2008-08-01T00:00:00Z